TWM645058U - A medication integration evaluation and intelligent query system - Google Patents

A medication integration evaluation and intelligent query system Download PDF

Info

Publication number
TWM645058U
TWM645058U TW112204654U TW112204654U TWM645058U TW M645058 U TWM645058 U TW M645058U TW 112204654 U TW112204654 U TW 112204654U TW 112204654 U TW112204654 U TW 112204654U TW M645058 U TWM645058 U TW M645058U
Authority
TW
Taiwan
Prior art keywords
information
database
medication
drug
integrated
Prior art date
Application number
TW112204654U
Other languages
Chinese (zh)
Inventor
沈明志
陳立材
Original Assignee
大樹醫藥股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 大樹醫藥股份有限公司 filed Critical 大樹醫藥股份有限公司
Priority to TW112204654U priority Critical patent/TWM645058U/en
Publication of TWM645058U publication Critical patent/TWM645058U/en

Links

Images

Abstract

A medication integration evaluation and intelligent query system, including: an input module, connected to the integration module for information transmission, so as to provide the user with the information to be searched for, and send the information to the integration module; the integration module, used to receive information from the input module, the integration module includes: a core unit that receives information from the input module and sends it to a display module after integration; a database that connects to the core unit for information transmission; and the expansion unit is connected to the database to update and maintain the database at any time. According to the latest drug information and medical-related research reports, the database is continuously updated and corrected; the display module is connected to the integrated module carry out information transmission, and display the result information after receiving the core unit integration.

Description

用藥整合評估暨智能查詢系統Medication Integrated Assessment and Intelligent Query System

本新型涉及用藥整合評估暨智能查詢系統,其整合判斷不同藥物的交互作用並給出用藥建議,達到避免用藥交互作用或其他風險之效果。This new model relates to an integrated medication assessment and intelligent query system, which integrates and judges the interactions of different medications and gives medication recommendations to avoid medication interactions or other risks.

在過去,醫生和藥師必須依靠人工手動檢查每個患者的用藥情況,這是非常耗時且容易出錯的。一般而言,處方箋的檢核是由藥師依據自身的知識判斷用藥相關問題, 或是由一般藥物單一查詢系統來查詢該單一藥物對該病患可能產生的用藥須知, 以此作為提醒病患用藥時, 需要注意的事項, 以免發生風險, 或是可提早讓病患有用藥的心理準備。In the past, doctors and pharmacists had to rely on humans to manually check each patient's medication, which was time-consuming and error-prone. Generally speaking, the review of prescriptions involves pharmacists judging medication-related issues based on their own knowledge, or using the general drug single query system to query the possible medication instructions for the single drug for the patient, as a reminder to the patient. When taking medication, you need to pay attention to things to avoid risks, or to prepare patients mentally for taking medication in advance.

然而,一般藥師不見得具有完整的知識、經驗或專家系統可輔助來發現或驗證用藥相關問題,而且一般醫院所建置的藥物資訊及外觀辨識查詢系統,目前尚欠缺整合其他多樣化之用藥問題評估系統來一併使用,以致停留在查詢一般藥物資訊的基本功能而已, 因此藥師在評估及檢核藥物上會有下列缺失:However, ordinary pharmacists may not have complete knowledge, experience or expert systems to assist in discovering or verifying medication-related problems, and the drug information and appearance identification query systems established by general hospitals currently lack the ability to integrate other diverse medication issues. The evaluation system is used together, so that it only stays at the basic function of querying general drug information. Therefore, pharmacists will have the following deficiencies in evaluating and checking drugs:

首先,許多先前的用藥評估系統只能分析單一藥物對患者的影響,而缺乏整合不同藥物的能力。這導致醫生和藥師需要手動整合不同的藥物訊息,可能導致錯誤的判斷和不良反應的風險。基於此,用藥整合評估暨智能查詢系統可以整合多種藥物訊息,並進行綜合評估,從而提高用藥評估的精確度和全面性。First, many previous medication assessment systems can only analyze the impact of a single drug on a patient and lack the ability to integrate different drugs. This results in doctors and pharmacists needing to manually integrate different drug information, potentially leading to erroneous judgments and the risk of adverse reactions. Based on this, the integrated medication evaluation and intelligent query system can integrate multiple drug information and conduct a comprehensive assessment, thereby improving the accuracy and comprehensiveness of medication assessment.

其次,先前的用藥評估系統大多依賴於手動輸入患者的藥物訊息,這需要大量的時間和人力成本。此外,手動輸入可能存在錯誤,進一步增加了不必要的風險。為解決這一問題,用藥整合評估暨智能查詢系統可以自動從醫療記錄中提取患者的用藥訊息,從而提高了用藥評估的效率和精確度。Secondly, most of the previous medication evaluation systems relied on manual input of patients’ medication information, which required a lot of time and labor costs. Additionally, manual entry may contain errors, further increasing unnecessary risk. To solve this problem, the integrated medication evaluation and intelligent query system can automatically extract the patient's medication information from medical records, thereby improving the efficiency and accuracy of medication assessment.

第三,先前的用藥評估系統可能存在對藥物訊息的更新速度較慢的問題。隨著新藥的不斷推出和舊藥的更新,用藥評估系統需要保持與最新藥物訊息同步。基於此,用藥整合評估暨智能查詢系統可以實時更新最新的藥物訊息,保持用藥評估的準確性和及時性。Third, the previous medication evaluation system may have a problem of slow updating of medication information. As new drugs are continuously introduced and old drugs are updated, the medication evaluation system needs to keep pace with the latest drug information. Based on this, the integrated medication assessment and intelligent query system can update the latest medication information in real time to maintain the accuracy and timeliness of medication assessment.

第四,先前的用藥評估系統可能存在對用藥風險的評估不足的問題。許多患者可能存在多種疾病和用藥情況,需要綜合考慮不同的風險因素進行評估。基於此,用藥整合評估暨智能查詢系統可以根據患者的疾病和用藥情況進行綜合評估,提高用藥風險的評估精確度和全面性。Fourth, previous medication assessment systems may have insufficient assessment of medication risks. Many patients may have multiple medical conditions and medications that require a comprehensive assessment that takes into account different risk factors. Based on this, the integrated medication assessment and intelligent query system can conduct a comprehensive assessment based on the patient's disease and medication status, improving the accuracy and comprehensiveness of medication risk assessment.

第五,先前的用藥評估系統可能存在缺乏個性化評估的問題。由於每個患者的生理狀態和用藥情況都不同,因此需要根據個人情況進行評估和建議。基於此,用藥整合評估暨智能查詢系統可以基於患者的生理狀態和用藥情況進行個性化評估,從而提供更精確的用藥建議。Fifth, previous medication assessment systems may suffer from a lack of personalized assessment. Because each patient's physiological state and medication use are different, assessment and recommendations need to be made on an individual basis. Based on this, the integrated medication assessment and intelligent query system can conduct personalized assessments based on the patient's physiological state and medication status, thereby providing more accurate medication recommendations.

第六,藥師評估藥物資訊時很可能會缺少某部份的考量,藥師要具備有多元化的知識或是經驗值才有辦法完整並精確的檢核用藥, 因此並不一定每個藥師都可以精準評估用藥。Sixth, pharmacists may lack some considerations when evaluating drug information. Pharmacists must have diversified knowledge or experience to fully and accurately check medications. Therefore, not every pharmacist can Accurately evaluate medication.

第七,藥師要查詢藥物之間或與健康食品的交叉作用資訊需要耗費更多時間,並非所有藥師都具備非常完整的知識或經驗,所以如果是初階藥師或是一般人要做出多元藥物或食品的交叉查詢評估的話, 可能要翻閱很多資訊才能作出判斷。Seventh, it takes more time for pharmacists to search for information on cross-interactions between drugs or with health foods. Not all pharmacists have very complete knowledge or experience, so if they are junior pharmacists or ordinary people who want to make multiple drugs or For cross-checking and evaluation of food products, you may need to read a lot of information before making a judgment.

因此,如果能夠提供藥師或是任何使用者,都可以自行對於該藥物資訊做個多元化的整合性評估,將可提早預防發生交互作用的情況,避免因藥師或是醫護人員的評估缺失而導致交互作用產生的意外風險。Therefore, if pharmacists or any users can make a comprehensive and diversified evaluation of the drug information, interactions can be prevented early and avoid errors caused by lack of evaluation by pharmacists or medical staff. Unintended risks arising from interactions.

是以,本案創作人在觀察到上述缺失後,認為習用之用藥評估系統仍有進一步改良之必要,而遂有本創作之產生。Therefore, after observing the above-mentioned deficiencies, the creator of this case believed that there is still a need for further improvement in the commonly used drug evaluation system, and thus this creation came into being.

為了解決上述問題,本新型的目的在於用藥整合評估暨智能查詢系統可以解決先前用藥評估系統存在的許多問題,包括整合多種藥物訊息、自動提取患者用藥訊息、實時更新最新的藥物訊息、綜合考慮不同的風險因素進行評估以及基於個人情況進行個性化評估等。通過這些改進,用藥整合評估暨智能查詢系統可以提高用藥評估的精確度、全面性、效率和個性化水平,從而為患者提供更好的用藥建議,減少不必要的風險和負擔。這些優勢將有助於提高用藥評估的標準和水平,並對醫療行業和患者帶來更多的益處。In order to solve the above problems, the purpose of this new model is that the integrated medication evaluation and intelligent query system can solve many problems existing in the previous medication evaluation system, including integrating multiple drug information, automatically extracting patient medication information, updating the latest drug information in real time, comprehensively considering different Assessment of risk factors and personalized assessment based on individual circumstances. Through these improvements, the integrated medication evaluation and intelligent query system can improve the accuracy, comprehensiveness, efficiency and personalized level of medication assessment, thereby providing patients with better medication recommendations and reducing unnecessary risks and burdens. These advantages will help improve the standards and levels of medication evaluation and bring more benefits to the medical industry and patients.

為了達成前述的目的,本新型揭露了用藥整合評估暨智能查詢系統,包括: 輸入裝置, 連接整合模組進行資訊傳輸,以提供使用者輸入欲搜尋之資訊, 並將該資訊傳送到該整合模組;該整合模組, 設置於實體伺服器, 用以接收來自該輸入裝置傳來之資訊, 該整合模組包含:核心單元,接收輸入裝置傳來的資訊並經整合後發送顯示裝置;資料庫,連接核心單元以進行資訊傳輸;以及擴充單元,與資料庫連接以隨時進行更新及維護該資料庫, 根據最新的藥品資訊及醫藥相關之研究報告, 對於該資料庫持續進行更新及修正;該顯示裝置, 連接該整合模組進行資訊傳輸, 將接收該核心單元整合後之結果資訊顯示出來;其中,該輸入裝置、該整合模組以及該顯示裝置相互連接以傳遞資訊。In order to achieve the aforementioned purpose, the present invention discloses an integrated medication evaluation and intelligent inquiry system, including: an input device, connected to an integrated module for information transmission, to provide the user with input of information to be searched, and to transmit the information to the integrated module. group; the integration module is installed on the physical server to receive information from the input device. The integration module includes: a core unit that receives information from the input device and sends it to the display device after integration; data The database is connected to the core unit for information transmission; and the expansion unit is connected to the database to update and maintain the database at any time. The database is continuously updated and revised based on the latest drug information and medical-related research reports; The display device is connected to the integration module for information transmission, and displays the result information after receiving the integration of the core unit; wherein, the input device, the integration module and the display device are connected to each other to transmit information.

在一較佳實施例中,該資料庫包括藥品資訊資料庫、西藥之間交互作用資料庫、中藥之間交互作用資料庫、中西藥交互作用資料庫、藥物與食物交互作用資料庫、藥物與健康食品交互作用資料庫以及年長者用藥安全資訊資料庫。In a preferred embodiment, the database includes a drug information database, an interaction database between Western medicines, an interaction database between Chinese medicines, an interaction database between Chinese and Western medicines, a drug-food interaction database, a drug-food interaction database, and a drug-food interaction database. Health Food Interaction Database and Elderly Medication Safety Information Database.

在一較佳實施例中,該輸入裝置可以為二維碼掃描單元, 透過二維碼掃描單元對具有二維碼的處方箋掃描後, 將該掃描後資訊傳送到該整合模組。In a preferred embodiment, the input device may be a QR code scanning unit. After scanning the prescription with the QR code through the QR code scanning unit, the scanned information is transmitted to the integrated module.

在一較佳實施例中,該藥品資訊資料庫包括有藥物資訊、高危險藥物資訊、藥物外觀資訊。In a preferred embodiment, the drug information database includes drug information, high-risk drug information, and drug appearance information.

在一較佳實施例中,該年長者用藥安全資訊資料庫包括有潛在不適合年長者使用的藥物資訊、不能破壞藥物劑型的藥物資訊、易導致跌倒的藥物資訊。In a preferred embodiment, the drug safety information database for the elderly includes drug information that is potentially unsuitable for the elderly, drug information that cannot damage drug dosage forms, and drug information that may easily cause falls.

本新型還揭露了一種用藥整合評估暨智能查詢方法,包括:S1:令輸入裝置與整合模組資訊傳輸,以提供使用者輸入欲搜尋之資訊, 並將該資訊傳送到該整合模組;S2:令該整合模組接收來自該輸入裝置傳來之資訊,該整合模組執行包含:S3:令核心單元接收輸入裝置傳來的資訊並經整合後發送顯示裝置;S4:令資料庫連接核心單元以進行資訊傳輸;以及S5:令擴充單元與資料庫連接以隨時進行更新及維護該資料庫, 根據最新的藥物資訊及醫藥相關之研究報告, 對於該資料庫持續進行更新及修正;以及S6:令該顯示裝置連接該整合模組進行資訊傳輸, 將接收該核心單元整合後之結果資訊顯示出來。This model also discloses an integrated medication assessment and intelligent query method, including: S1: transmitting information between the input device and the integrated module to provide the user with input of information to be searched, and transmitting the information to the integrated module; S2 : Make the integration module receive information from the input device. The execution of the integration module includes: S3: Make the core unit receive the information from the input device and send it to the display device after integration; S4: Make the database connect to the core unit for information transmission; and S5: Connect the expansion unit to the database to update and maintain the database at any time, and continuously update and modify the database based on the latest drug information and medical-related research reports; and S6 : Allow the display device to connect to the integration module for information transmission, and display the integrated result information received from the core unit.

在一較佳實施例中,該結果資訊進一步包括目前值班的資深藥師聯繫方式,以供諮詢系統未能解決問題之需。In a preferred embodiment, the result information further includes the contact information of the senior pharmacist currently on duty in case the problem cannot be solved by the consultation system.

在一較佳實施例中,該研究報告的來源可人為設定以增刪調整。In a preferred embodiment, the source of the research report can be manually set to be added, deleted, and adjusted.

在一較佳實施例中,該資料庫的來源可人為設定以增刪調整。In a preferred embodiment, the source of the database can be manually set to add, delete, and adjust.

綜上可知,本新型提供的用藥整合評估暨智能查詢系統,包括: 輸入裝置, 連接整合模組進行資訊傳輸,以提供使用者輸入欲搜尋之資訊, 並將該資訊傳送到該整合模組;該整合模組, 設置於實體伺服器, 用以接收來自該輸入裝置傳來之資訊, 該整合模組包含:核心單元,接收輸入裝置傳來的資訊並經整合後發送顯示裝置;資料庫,連接核心單元以進行資訊傳輸;以及擴充單元,與資料庫連接以隨時進行更新及維護該資料庫, 根據最新的藥品資訊及醫藥相關之研究報告, 對於該資料庫持續進行更新及修正;該顯示裝置, 連接該整合模組進行資訊傳輸, 將接收該核心單元整合後之結果資訊顯示出來,達到提早預防發生各種交互作用的情況,避免因藥師或是醫護人員的評估缺失而導致交互作用產生的意外風險。In summary, it can be seen that the integrated medication evaluation and intelligent query system provided by the present model includes: an input device, connected to the integration module for information transmission, to allow the user to input the information they want to search, and transmit the information to the integration module; The integration module is installed on the physical server to receive information from the input device. The integration module includes: a core unit that receives information from the input device and integrates it before sending to the display device; a database, Connect the core unit for information transmission; and the expansion unit is connected to the database to update and maintain the database at any time. Based on the latest drug information and medical-related research reports, the database is continuously updated and revised; the display The device is connected to the integration module for information transmission, and displays the result information after receiving the integration of the core unit, so as to prevent various interactions in advance and avoid interactions caused by lack of evaluation by pharmacists or medical staff. Unexpected risks.

不同附圖中的相同參考號代表相同或類似的元件,並因此執行類似的功能。此外,為了簡化描述,省略了對眾所周知的步驟和元件的描述和細節。此外,在本新型內容的以下詳細描述中,為了提供對本新型內容的全面理解,列出了許多具體細節。然而,可以理解的是,本新型的內容可以在沒有這些具體細節的情況下進行實施。在其他情況下,眾所周知的方法、程序和組件沒有被詳細描述,以避免不必要地掩蓋本新型的各個方面。以下將進一步說明和描述各種實施例的例子。可以理解的是,這裡的描述並不是為了將請求項限制在所描述的具體實施例中。相反地,旨在涵蓋可能包括在由所附請求項界定的本新型的精神和範圍內的替代物、修改和均等物。 The same reference numbers in different drawings represent the same or similar elements, and therefore perform similar functions. Furthermore, descriptions and details of well-known steps and elements are omitted to simplify the description. Additionally, in the following detailed description of the present invention, numerous specific details are set forth in order to provide a thorough understanding of the present invention. However, it is understood that the teachings of the present invention may be practiced without these specific details. In other instances, well-known methods, procedures and components have not been described in detail to avoid unnecessarily obscuring aspects of the present invention. Examples of various embodiments are further illustrated and described below. It will be understood that the description herein is not intended to limit the claims to the specific embodiments described. On the contrary, the intention is to cover alternatives, modifications, and equivalents as may be included within the spirit and scope of the invention as defined by the appended claims.

本新型使用的術語僅用於描述特定的實施例,並不旨在限制本新型內容。如本文所使用的單數形式:「一」也可以包括複數形式,除非上下文另有明確說明。將進一步理解,「包括」和「包括」當在本說明書中使用時,指定存在所述特徵、整體、操作、元件和/或組件,但不排除存在或添加一個或多個其他特徵、整體、操作、元件、組件和/或其部分。 The terms used in the present invention are only used to describe specific embodiments and are not intended to limit the content of the present invention. As used herein, the singular form: "a" may also include the plural form unless the context clearly indicates otherwise. It will be further understood that "comprising" and "comprising", when used in this specification, specify the presence of stated features, integers, operations, elements and/or components but do not exclude the presence or addition of one or more other features, integers, elements, integers, operations, elements, assemblies and/or parts thereof.

新型創作人研究發現,影響用藥整合評估暨智能查詢系統的因素主要如下,應該在系統開發時加以考量: New Creator's research found that the main factors affecting the integrated medication assessment and intelligent query system are as follows, which should be considered during system development:

其一,醫療環境:不同國家、地區的醫療體系和藥品監管機構的要求不同,對於用藥整合評估暨智能查詢系統的開發和應用有著很大的影響。例如,一些國家和地區要求藥品進行嚴格的臨床試驗和審批才能上市,這可能會導致用藥整合評估暨智能查詢系統的數據庫更新速度較慢。 First, the medical environment: Different countries and regions have different requirements for medical systems and drug regulatory agencies, which have a great impact on the development and application of integrated medication evaluation and intelligent query systems. For example, some countries and regions require drugs to undergo strict clinical trials and approval before they can be marketed, which may result in slower database updates for the integrated drug evaluation and intelligent query system.

其二,技術水平:用藥整合評估暨智能查詢系統需要藥師具備較高的技術水平及經驗,包括醫學知識、藥理學知識等。因此,系統的開發和應用需要專業人員的積極參與和支持。 Second, technical level: The integrated medication evaluation and intelligent query system requires pharmacists to have a high technical level and experience, including medical knowledge, pharmacological knowledge, etc. Therefore, the development and application of the system require the active participation and support of professionals.

其三,安全性:用藥整合評估暨智能查詢系統需要考慮用藥的安全性,尤其是對於長期用藥的患者。藥師要評估不同藥品的副作用、相互作用等風險,並提供對患者個體化用藥的建議,以確保患者用藥的安全性。 Third, safety: The integrated medication assessment and intelligent query system needs to consider the safety of medication, especially for patients who take medication for a long time. Pharmacists should evaluate the side effects, interactions and other risks of different drugs and provide patients with personalized medication recommendations to ensure the safety of patients' medication.

其四,成本效益:用藥整合評估暨智能查詢系統的開發和應用需要耗費大量的資源,包括人力、物力、財力等。因此,需要考慮系統的成本效益,並評估系統對醫療費用和患者生活品質的影響,以確保系統的可持續發展。 Fourth, cost-effectiveness: The development and application of integrated medication assessment and intelligent query systems require a large amount of resources, including manpower, material resources, financial resources, etc. Therefore, it is necessary to consider the cost-effectiveness of the system and evaluate the impact of the system on medical costs and patients' quality of life to ensure the sustainable development of the system.

正如先前技術部分所述,當前藥師在評估及檢核藥物上會有七項缺失以及影響用藥整合評估暨智能查詢系統的四項因素,基於此,本新型提供用藥整合評估暨智能查詢系統的完整解決方案,包括:整合性:該系統整合了多個不同的資料庫,包括藥品資訊、交互作用資料庫、年長者用藥安全資訊等,使得用戶能夠輕鬆地查詢到相關的藥品訊息和交互作用訊息,從而減少尋找資訊的時間和精力。智能化:該系統擁有智能查詢功能,用戶可以透過二維碼掃描單元快速掃描處方箋,系統會自動解析處方箋中的藥品名稱和用量,並提供相關的用藥建議。同時,該系統還能進行自動化分析,檢測潛在的交互作用,從而提高了用戶的用藥安全性。人性化:系統還包括聯繫資深藥師的功能,如果用戶對用藥建議仍有疑問或需要進一步的諮詢,系統將提供資深藥師的聯繫方式,使用戶能夠獲得更加專業的意見和建議。經本新型提供之水質優化裝置最終達到零耗能便攜型水質優化裝置之目標。As mentioned in the previous technical section, there are currently seven deficiencies that pharmacists have in evaluating and checking drugs and four factors that affect the integrated medication assessment and intelligent query system. Based on this, this new model provides a complete integrated medication assessment and intelligent query system. Solutions include: Integration: The system integrates multiple different databases, including drug information, interaction databases, elderly drug safety information, etc., allowing users to easily query relevant drug information and interaction information. , thereby reducing the time and energy spent searching for information. Intelligent: The system has an intelligent query function. Users can quickly scan the prescription through the QR code scanning unit. The system will automatically analyze the drug name and dosage in the prescription and provide relevant medication suggestions. At the same time, the system can also perform automated analysis to detect potential interactions, thereby improving medication safety for users. Humanization: The system also includes the function of contacting a senior pharmacist. If the user still has questions about medication recommendations or needs further consultation, the system will provide the contact information of the senior pharmacist so that the user can obtain more professional opinions and suggestions. The water quality optimization device provided by this new model finally achieves the goal of a zero-energy consumption portable water quality optimization device.

以上是本申請的核心思想,下面將結合本新型實施例中的附圖,對本新型實施例中的實施方式進行清楚、完整地描述,顯然,所描述的實施例僅僅是本新型一部分實施例,而不是全部的實施例。基於本新型中的實施例,所屬技術領域具有通常知識者在沒有做出進步性創作前提下所獲得的所有其他實施例,都屬於本新型保護的範圍。The above is the core idea of the present application. The following will clearly and completely describe the embodiments of the present invention in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention. Not all examples. Based on the embodiments of the present invention, all other embodiments obtained by those with ordinary knowledge in the technical field without making any progressive creations fall within the scope of protection of the present invention.

在下面的描述中闡述了很多具體細節以便於充分理解本新型,但是本新型還可以採用其他不同於在此描述的其它方式來實施,所屬技術領域具有通常知識者可以在不違背本新型內涵的情況下做類似推廣,因此本新型不受下面公開的具體實施例的限制。Many specific details are set forth in the following description in order to fully understand the present invention. However, the present invention can also be implemented in other ways different from those described here. Those with ordinary knowledge in the technical field can implement the invention without violating the connotation of the present invention. Similar promotion will be made under different circumstances, so the present invention is not limited by the specific embodiments disclosed below.

其次,本新型結合示意圖進行詳細描述,在詳述本新型實施例時,為便於說明,所述示意圖只是示例,其在此不應限制本新型保護的範圍,為了清楚呈現本新型的各實施例的差異,在介紹各實施例時,相同的元件或描述將省略,僅針對差異之處特別介紹。Secondly, the present invention is described in detail with reference to schematic diagrams. When describing the embodiments of the present invention in detail, for the convenience of explanation, the schematic diagrams are only examples, which should not limit the scope of protection of the present invention. In order to clearly present the various embodiments of the present invention When introducing each embodiment, the same elements or descriptions will be omitted, and only the differences will be specifically introduced.

如圖1所示,在一較佳實施例中,本新型提供的用藥整合評估暨智能查詢系統1,包括: 輸入裝置100, 連接整合模組200進行資訊傳輸,以提供使用者2輸入欲搜尋之資訊, 並將該資訊傳送到該整合模組200;該整合模組200, 設置於實體伺服器, 用以接收來自該輸入裝置100傳來之資訊, 該整合模組200包含:核心單元210,接收輸入裝置100傳來的資訊並經整合後發送顯示裝置300;資料庫220,連接核心單元210以進行資訊傳輸;以及擴充單元230,與資料庫220連接以隨時進行更新及維護該資料庫220, 根據最新的藥品資訊及醫藥相關之研究報告, 對於該資料庫220持續進行更新及修正;該顯示裝置300, 連接該整合模組200進行資訊傳輸, 將接收該核心單元210整合後之結果資訊顯示出來,達到輔助藥師整合多種藥物訊息,並進行綜合評估,從而提高用藥評估的精確度和全面性,其中,顯示裝置300也可將結果資訊以藥物仿單的方式呈現, 提供使用者2列印或下載,該輸入裝置100、該整合模組200以及該顯示裝置300相互連接以傳遞資訊。As shown in Figure 1, in a preferred embodiment, the integrated medication evaluation and intelligent query system 1 provided by the present invention includes: an input device 100, connected to the integration module 200 for information transmission, to provide the user 2 with input to search information, and transmits the information to the integration module 200; the integration module 200 is configured on a physical server to receive information from the input device 100. The integration module 200 includes: a core unit 210 , receives the information from the input device 100 and sends it to the display device 300 after integration; the database 220 is connected to the core unit 210 for information transmission; and the expansion unit 230 is connected to the database 220 to update and maintain the database at any time 220. Based on the latest drug information and medical-related research reports, the database 220 is continuously updated and revised; the display device 300 is connected to the integration module 200 for information transmission and will receive the integrated results of the core unit 210 The information is displayed to assist the pharmacist in integrating multiple drug information and conducting comprehensive evaluation, thereby improving the accuracy and comprehensiveness of drug evaluation. Among them, the display device 300 can also present the result information in the form of a drug formula, providing the user 2 Printing or downloading, the input device 100, the integration module 200 and the display device 300 are connected to each other to transmit information.

具體地,在一較佳實施例中,該輸入裝置100可以為二維碼掃描單元, 透過二維碼掃描單元對具有二維碼的處方箋掃描後, 將該掃描後資訊傳送到該整合模組200,透過掃描藥品的二維碼,可以快速識別其中儲存的信息,便於信息的傳遞和處理。Specifically, in a preferred embodiment, the input device 100 can be a QR code scanning unit. After scanning the prescription with the QR code through the QR code scanning unit, the scanned information is transmitted to the integrated module. Group 200, by scanning the QR code of the medicine, the information stored in it can be quickly identified, which facilitates the transmission and processing of information.

具體地,在一較佳實施例中,該藥品資訊資料庫221包括有藥物資訊、高危險藥物資訊、藥物外觀資訊,透過藥品資訊資料庫221, 任何使用者2都可了解到藥品的基本資訊,包含中藥及西藥,並且可注意到具有高危險的藥品, 可提供使用者2在使用上更加留意,達到便於使用者2了解訊息的效果。Specifically, in a preferred embodiment, the drug information database 221 includes drug information, high-risk drug information, and drug appearance information. Through the drug information database 221, any user 2 can learn the basic information of the drug. , including Chinese medicine and Western medicine, and can pay attention to high-risk drugs, which can provide users 2 with more attention in use, achieving the effect of making it easier for users 2 to understand the information.

具體地,如圖2所示,在一較佳實施例中,該資料庫220包括藥品資訊資料庫221、西藥交互作用資料庫222、中藥交互作用資料庫223、中西藥交互作用資料庫224、藥物與食物交互作用資料庫225、藥物與健康食品交互作用資料庫226以及年長者用藥安全資訊資料庫227,以完整地蒐整藥物交互作用來提供使用者2參考,核心單元210 可將各項資訊交叉查詢後整合成結果資訊,使該結果資訊的內容除了有藥物的基本資訊,也能有各種中藥、西藥、食品、年長者用藥等多元化交互影響的資訊, 提供任何使用者2都能一目了然用藥所需的注意資訊。Specifically, as shown in Figure 2, in a preferred embodiment, the database 220 includes a drug information database 221, a Western medicine interaction database 222, a Chinese medicine interaction database 223, a Chinese and Western medicine interaction database 224, The drug and food interaction database 225, the drug and health food interaction database 226, and the elderly medication safety information database 227 are used to completely search for drug interactions to provide users 2 with reference. The core unit 210 can combine various items. The information is cross-queried and integrated into the result information, so that the content of the result information includes not only basic information about drugs, but also diversified interactive information such as various Chinese medicines, Western medicines, foods, and medications for the elderly, providing any user2 with the ability to The precautionary information required for medication is clear at a glance.

具體地,在一較佳實施例中,該年長者用藥安全資訊資料庫227包括有潛在不適合年長者使用的藥物資訊、不能破壞藥物劑型的藥物資訊、易導致跌倒的藥物資訊,透過年長者用藥安全資訊資料庫227內的資訊,可讓使用者2在查詢藥物時,更能注意到年長者用藥可能發生的情況,包含難以吞嚥、具有暈眩副作用的藥物可能導致年長者跌倒… 等,可提供使用者2在年長者用藥上獲得更精確的提示達到對於年長者需要特別注意事項的額外提醒效果。Specifically, in a preferred embodiment, the elderly medication safety information database 227 includes drug information that is potentially unsuitable for the elderly, drug information that cannot damage drug dosage forms, and drug information that may easily cause falls. The information in the safety information database 227 allows the user 2 to pay more attention to the situations that may occur when the elderly take medication when inquiring about drugs, including drugs that are difficult to swallow and have dizzy side effects that may cause the elderly to fall... etc., etc. Provide user 2 with more precise reminders on the elderly's medication use to achieve an additional reminder effect for the elderly who need special attention.

具體地,如圖3所示,在一較佳實施例中,使用者2在使用用藥整合評估暨查詢智能系統1的過程中,有任何問題不能解決的問題,例如:藥物交互作用不明,該結果資訊進一步包括目前值班的資深藥師4聯繫方式,以供消費者3諮詢系統未能解決問題之需。Specifically, as shown in Figure 3, in a preferred embodiment, the user 2 has any problems that cannot be solved during the process of using the integrated medication assessment and query intelligent system 1, such as: unknown drug interactions. The result information further includes the contact information of the senior pharmacist 4 currently on duty for consumers 3 if the consultation system fails to solve the problem.

如圖4所示,在一較佳實施例中,一種用藥整合評估暨智能查詢方法,包括:S1:令輸入裝置與整合模組資訊傳輸,以提供使用者2輸入欲搜尋之資訊, 並將該資訊傳送到該整合模組;S2:令該整合模組接收來自該輸入裝置傳來之資訊,該整合模組執行包含:S3:令核心單元接收輸入裝置傳來的資訊並經整合後發送顯示裝置;S4:令資料庫連接核心單元以進行資訊傳輸;以及S5:令擴充單元與資料庫連接以隨時進行更新及維護該資料庫, 根據最新的藥物資訊及醫藥相關之研究報告, 對於該資料庫持續進行更新及修正;以及S6:令該顯示裝置連接該整合模組進行資訊傳輸, 將接收該核心單元整合後之結果資訊顯示出來,以提供使用者操作用藥整合評估暨智能查詢系統1之方法。As shown in Figure 4, in a preferred embodiment, a medication integrated assessment and intelligent query method includes: S1: causing the input device and the integrated module to transmit information to provide the user 2 to input the information they want to search, and The information is sent to the integration module; S2: Let the integration module receive the information from the input device. The execution of the integration module includes: S3: Let the core unit receive the information from the input device and send it after integration. Display device; S4: Connect the database to the core unit for information transmission; and S5: Connect the expansion unit to the database to update and maintain the database at any time. According to the latest drug information and medical-related research reports, for this The database is continuously updated and revised; and S6: The display device is connected to the integrated module for information transmission, and the result information after receiving the integration of the core unit is displayed to provide the user with the ability to operate the integrated medication evaluation and intelligent query system 1 method.

具體地,該結果資訊進一步包括目前值班的資深藥師聯繫方式,以供諮詢系統未能解決問題之需。Specifically, the result information further includes the contact information of the senior pharmacist currently on duty, in case the problem cannot be solved by the consultation system.

具體地,該研究報告的來源可人為設定以增刪調整。Specifically, the source of the research report can be artificially set to add, delete, and adjust.

具體地,該資料庫的來源可人為設定以增刪調整。Specifically, the source of the database can be manually set to add, delete, and adjust.

藉由前述之技術特徵, 使用者以二維碼掃描單元針對處方箋上的二維碼, 也就是QRCODE ( 快速響應矩陣圖碼;Quick Response Code ) , 該整合模組 即收到掃描後的資訊; 如果使用者掃描出藥品成分名為「Warfarin」, 整合模組的核心單元會接收到掃描的「Warfarin」資訊後, 再搜尋資料庫中的藥品資訊資料庫、西藥交互作用資料庫、中藥交互作用資料庫、中西藥交互作用資料庫、藥物與食物交互作用資料庫、藥物與健康食品交互作用資料庫以及年長者用藥安全資訊資料庫搜尋「Warfarin」相關的資訊,而後核心單元會整合成結果資訊,再將結果資訊傳送至顯示裝置, 使用者即可再顯示裝置查看除了有關「Warfarin」的藥物資訊外,還能看到其與中藥、西藥、食品、年長者用藥安全等交叉查詢後的資訊, 並且可將結果資訊以藥物仿單的方式下載查看。With the aforementioned technical features, the user uses the QR code scanning unit to scan the QR code on the prescription, which is QRCODE (Quick Response Code; Quick Response Code), and the integrated module receives the scanned information. ; If the user scans the drug ingredient name "Warfarin", the core unit of the integration module will receive the scanned "Warfarin" information and then search the drug information database, Western medicine interaction database, and Chinese medicine interaction in the database. Search for information related to "Warfarin" in the Action Database, Chinese and Western Medicine Interaction Database, Drug-Food Interaction Database, Drug-Healthy Food Interaction Database, and Elderly Medication Safety Information Database, and then the core units will be integrated into the results. information, and then transmit the result information to the display device. The user can then display the device to view in addition to drug information about "Warfarin", and also see its cross-query with Chinese medicine, Western medicine, food, drug safety for the elderly, etc. Information, and the result information can be downloaded and viewed in the form of drug instructions.

藉由前述的查詢結果, 藥師可用於判斷各種處方箋之用藥相關問題,除了可以查詢基本的藥物及外觀資訊之外,同時可以比對出年長者用藥安全資訊、中西藥交互作用資訊、中藥交互作用資訊、藥物與健康食品交互作用資訊、西藥之間交互作用資訊、藥物與食物交互作用資訊,而具有交叉比對及查詢用藥正確資訊及評估用藥相關問題的多重功能; 病人則可透過本新型即時查詢自己目前正在使用的藥物及外觀資訊, 或直接下載藥品仿單閱讀,因此,藉由本新型可提供使用者,如:藥師、或其他醫療相關人員、或病人對於藥事照護及處方適當性評估進行判斷性服務,任何使用者皆可用於檢驗與查核該處方是否恰當, 因此本新型可提供更精準且更簡單的評估用藥的方式。倘若在藥品交互作用資訊內容中有任何問題,也可與資深藥師聯繫並尋求解答。Through the aforementioned query results, pharmacists can use it to determine medication-related issues on various prescriptions. In addition to querying basic drug and appearance information, pharmacists can also compare medication safety information for the elderly, interaction information between Chinese and Western medicines, and interaction between Chinese medicines. Action information, drug and health food interaction information, interaction information between Western medicines, drug and food interaction information, and has multiple functions of cross-referencing and querying correct medication information and evaluating medication-related issues; patients can use this new type of You can instantly check the drug and appearance information you are currently using, or directly download the drug instructions to read. Therefore, this new model can provide users, such as pharmacists, other medical-related personnel, or patients with drug care and prescription appropriateness. Evaluation provides a judgment service that any user can use to test and check whether the prescription is appropriate. Therefore, this new method can provide a more accurate and simpler way to evaluate medication. If you have any questions about the drug interaction information, you can also contact a senior pharmacist for answers.

最後,再將本新型的技術特徵及其可達成之技術功效彙整如下:Finally, the technical features of this new model and its achievable technical effects are summarized as follows:

其一,具有多元化整合查詢用藥資訊整合性:該系統整合了多個不同的資料庫,包括藥品資訊、交互作用資料庫、年長者用藥安全資訊等,使得用戶能夠輕鬆地查詢到相關的藥品訊息和交互作用訊息,從而減少尋找資訊的時間和精力。First, it has the ability to diversify and integrate medication information query: the system integrates multiple different databases, including drug information, interaction databases, medication safety information for the elderly, etc., allowing users to easily query related drugs. Messages and interactive messages, thereby reducing time and effort in finding information.

其二,具有輔助使用者判斷各種處方箋之用藥相關問題智能性:該系統擁有智能查詢功能,用戶可以透過二維碼掃描單元快速掃描處方箋,系統會自動解析處方箋中的藥品名稱和用量,並提供相關的用藥建議。同時,該系統還能進行自動化分析,檢測潛在的交互作用,從而提高了用戶的用藥安全性。Second, it has the intelligence to assist users in judging medication-related issues on various prescriptions: the system has an intelligent query function. Users can quickly scan prescriptions through the QR code scanning unit, and the system will automatically analyze the drug names and dosages in the prescriptions. , and provide relevant medication suggestions. At the same time, the system can also perform automated analysis to detect potential interactions, thereby improving medication safety for users.

其三,具有輔助使用者解決問題的人性化:具有交叉查詢的多元化資料庫,所以即使不一定具有完整各類型資訊的知識或經驗的藥師或醫師, 也都可以透過本新型交叉比對後, 獲得大數據整合後的藥物整體評估結果, 更精準且更簡單,系統還包括聯繫資深藥師的功能,如果使用者對用藥建議仍有疑問或需要進一步的諮詢,系統將提供資深藥師的聯繫方式,使用戶能夠獲得更加專業的意見和建議。Third, it is humanized to assist users in solving problems: it has a diversified database with cross-query, so even pharmacists or doctors who do not necessarily have complete knowledge or experience of various types of information can use this new type of cross-reference. , obtain the overall drug evaluation results after big data integration, which is more accurate and simpler. The system also includes the function of contacting a senior pharmacist. If the user still has questions about the medication recommendations or needs further consultation, the system will provide the contact information of the senior pharmacist. , enabling users to obtain more professional opinions and suggestions.

經本新型提供之用藥整合評估暨智能查詢系統最終達到多元化的整合性評估,將可提早預防發生交互作用的情況,避免因藥師或是醫護人員的評估缺失而導致交互作用產生的意外風險之目標。The medication integrated assessment and intelligent query system provided by this new model will ultimately achieve a diversified integrated assessment, which will prevent the occurrence of interactions in advance and avoid the unexpected risk of interactions caused by the lack of assessment by pharmacists or medical staff. .

以上已經詳細描述了本新型的各種實施例。然而,本新型內容所屬技術領域中具有通常知識者可以在不偏離本新型內容的範圍的情況下對上述實施例進行各種修改。因此,本新型的範圍不應局限於所描述的實施例,而應由下文所述的請求項以及其均等物來界定。Various embodiments of the present invention have been described in detail above. However, those with ordinary skill in the technical field to which the present invention belongs can make various modifications to the above embodiments without departing from the scope of the present invention. Therefore, the scope of the present invention should not be limited to the described embodiments, but should be defined by the claims set forth below and their equivalents.

1:用藥整合評估暨智能查詢系統 2:使用者 3:消費者 4:資深藥師 S1-S7:步驟 100:輸入裝置 200:整合模組 210:核心單元 220:資料庫 221:藥品資訊資料庫 222:西藥交互作用資料庫 223:中藥交互作用資料庫 224:中西藥交互作用資料庫 225:藥物與食物交互作用資料庫 226:藥物與健康食品交互作用資料庫 227:年長者用藥安全資訊資料庫 230:擴充單元 300:顯示裝置 1: Medication integrated assessment and intelligent query system 2:User 3:Consumer 4:Senior pharmacist S1-S7: Steps 100:Input device 200: Integrated modules 210: Core unit 220:Database 221: Drug information database 222: Western Drug Interaction Database 223: Traditional Chinese Medicine Interaction Database 224: Chinese and Western medicine interaction database 225: Drug-Food Interaction Database 226:Drug and health food interaction database 227: Medication safety information database for the elderly 230: Expansion unit 300:Display device

圖1是用藥整合評估暨智能查詢系統的示意圖;Figure 1 is a schematic diagram of the integrated medication assessment and intelligent query system;

圖2是用藥整合評估暨智能查詢系統的整合模組的示意圖;Figure 2 is a schematic diagram of the integration module of the integrated medication assessment and intelligent query system;

圖3是用藥整合評估暨智能查詢系統的運用情境的示意圖;Figure 3 is a schematic diagram of the application scenario of the integrated medication assessment and intelligent query system;

圖4是用藥整合評估暨智能查詢方法的示意圖。Figure 4 is a schematic diagram of the integrated medication assessment and intelligent query method.

100:輸入裝置 100:Input device

200:整合模組 200: Integrated modules

210:核心單元 210: Core unit

220:資料庫 220:Database

230:擴充單元 230: Expansion unit

300:顯示裝置 300:Display device

Claims (6)

一種用藥整合評估暨智能查詢系統,包括:輸入裝置,連接整合模組進行資訊傳輸,以提供使用者輸入欲搜尋之資訊,並將該資訊傳送到該整合模組;該整合模組,設置於實體伺服器,用以接收來自該輸入裝置傳來之資訊,該整合模組包含:核心單元,接收該輸入裝置傳來的資訊並經整合後發送顯示裝置;資料庫,連接該核心單元以進行資訊傳輸;以及擴充單元,與該資料庫連接以隨時進行更新及維護該資料庫,根據最新的藥品資訊及醫藥相關之研究報告,對於該資料庫持續進行更新及修正;該顯示裝置,連接該整合模組進行資訊傳輸,將接收該核心單元整合後之結果資訊顯示出來;其中,該輸入裝置、該整合模組以及該顯示裝置相互連接以傳遞資訊。 An integrated medication evaluation and intelligent query system, including: an input device connected to an integration module for information transmission to provide users with the information they want to search for, and transmit the information to the integration module; the integration module is provided in The physical server is used to receive information from the input device. The integration module includes: a core unit that receives the information from the input device and sends it to the display device after integration; a database that connects to the core unit for processing. Information transmission; and an expansion unit, connected to the database to update and maintain the database at any time, and to continuously update and correct the database based on the latest drug information and medical-related research reports; the display device, connected to the database The integration module transmits information and displays the integrated result information received from the core unit; wherein the input device, the integration module and the display device are connected to each other to transmit information. 如請求項1所述的用藥整合評估暨智能查詢系統,其中,該資料庫包括藥品資訊資料庫、西藥之間交互作用資料庫、中藥之間交互作用資料庫、中西藥交互作用資料庫、藥物與食物交互作用資料庫、藥物與健康食品交互作用資料庫以及年長者用藥安全資訊資料庫。 Integrated medication evaluation and intelligent query system as described in request item 1, wherein the database includes a drug information database, an interaction database between Western medicines, an interaction database between Chinese medicines, an interaction database between Chinese and Western medicines, a drug Food interaction database, drug and health food interaction database, and elderly medication safety information database. 如請求項1所述的用藥整合評估暨智能查詢系統,其中,該輸入裝置可以為二維碼掃描單元,透過二維碼掃描單元對具有二維碼的處方箋掃描後,將掃描後資訊傳送到該整合模組。 The integrated medication evaluation and intelligent inquiry system as described in claim 1, wherein the input device can be a QR code scanning unit, which scans the prescription with the QR code through the QR code scanning unit, and then transmits the scanned information. to the integrated module. 如請求項2所述的用藥整合評估暨智能查詢系統,其中,該藥品資訊資料庫包括有藥物資訊、高危險藥物資訊、藥物外觀資訊。 As described in claim 2, the integrated medication evaluation and intelligent query system, wherein the drug information database includes drug information, high-risk drug information, and drug appearance information. 如請求項2所述的用藥整合評估暨智能查詢系統,其中,該年長者用藥安全資訊資料庫包括有潛在不適合年長者使用的藥物資訊、不能破壞藥物劑型的藥物資訊、易導致跌倒的藥物資訊。 Integrated medication assessment and intelligent query system as described in request item 2, wherein the medication safety information database for the elderly includes information on medications that are potentially unsuitable for the elderly, information on medications that cannot damage medication dosage forms, and information on medications that can easily cause falls. . 如請求項1所述的用藥整合評估暨智能查詢系統,其中,該結果資訊進一步包括目前值班的資深藥師聯繫方式,以供諮詢該用藥整合評估暨智能查詢系統未能解決問題之需。 The integrated medication evaluation and intelligent inquiry system as described in request item 1, wherein the result information further includes the contact information of the senior pharmacist currently on duty for consultation if the integrated medication assessment and intelligent inquiry system cannot solve the problem.
TW112204654U 2023-05-11 2023-05-11 A medication integration evaluation and intelligent query system TWM645058U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW112204654U TWM645058U (en) 2023-05-11 2023-05-11 A medication integration evaluation and intelligent query system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW112204654U TWM645058U (en) 2023-05-11 2023-05-11 A medication integration evaluation and intelligent query system

Publications (1)

Publication Number Publication Date
TWM645058U true TWM645058U (en) 2023-08-11

Family

ID=88560110

Family Applications (1)

Application Number Title Priority Date Filing Date
TW112204654U TWM645058U (en) 2023-05-11 2023-05-11 A medication integration evaluation and intelligent query system

Country Status (1)

Country Link
TW (1) TWM645058U (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11949903B2 (en) 2011-05-31 2024-04-02 Sun Patent Trust Image decoding method and image decoding apparatus using candidate motion vectors

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11949903B2 (en) 2011-05-31 2024-04-02 Sun Patent Trust Image decoding method and image decoding apparatus using candidate motion vectors

Similar Documents

Publication Publication Date Title
Oyo-Ita et al. Interventions for improving coverage of childhood immunisation in low‐and middle‐income countries
Tamura et al. Physician intervention for medication reduction in a nursing home: the polypharmacy outcomes project
Fang et al. Pharmacists’ perception of pharmaceutical care in community pharmacy: a questionnaire survey in Northwest China
Alexander et al. The science of quality improvement implementation: developing capacity to make a difference
TWI444921B (en) Online system, method, and computer readable medium to facilitate providing health and wellness assistance
US11948668B2 (en) Individualized health platforms
Naughton et al. An evaluation of the appropriateness and safety of nurse and midwife prescribing in I reland
Schwappach et al. Communication barriers in counselling foreign-language patients in public pharmacies: threats to patient safety?
CN112735610A (en) Post-hospital follow-up system and follow-up method
Groom et al. Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems
TWM645058U (en) A medication integration evaluation and intelligent query system
Navarrete et al. Sexual and reproductive health services provided by community pharmacists: a scoping review
Cassar Flores et al. Use of the Delphi technique to determine safety features to be included in a neonatal and paediatric prescription chart
Hamner State of the science: posthospitalization nursing interventions in congestive heart failure
Nowalk et al. Evaluation of a toolkit to introduce standing orders for influenza and pneumococcal vaccination in adults: a multimodal pilot project
Collingsworth et al. Patient self-administration of medication: a review of the literature
Fung et al. Comparison of electronic pharmacy prescription records with manually collected medication histories in an emergency department
Ghazanfar et al. Hospital admission interviews are time-consuming with several interruptions
CN114974530A (en) Post-diagnosis follow-up method, system and storage medium
Cho et al. Acceptability and feasibility of the Leapfrog computerized physician order entry evaluation tool for hospitals outside the United States
US20160292366A1 (en) System and method of combining medicinal product information of medicaments
Dyer et al. Prison health discharge planning–evidence of an integrated care pathway or the end of the road?
US20040153339A1 (en) Method and system for handling medical information
Smith et al. Reduction of adverse drug events and medication errors in a community hospital setting
Chang et al. Real‐time display of laboratory testing status improves satisfaction levels in an emergency department: A pilot study